Skip to content
Tuesday, November 17, 2026
Brit Poker Online UK

Users Coming Off Anti-Obesity Jabs Regain Weight at a Quadrupled Rate Compared to Those on Conventional Diets

Illustration of pharmaceutical injection and weighing machine
Weight management involves ongoing approaches.

New research reveals that people who discontinue popular weight-loss injections like Mounjaro or Wegovy can put back on lost weight at a significantly accelerated pace than those who halt traditional lifestyle programs.

Published data in a leading medical journal demonstrates that while obese people often shed substantial amounts of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month once they quit.

"People buying such medications should be cognizant of the danger of quick weight regain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.

This pace of regain means a return to original weight within about one and a half years.

Weighing Treatments

The study, which reviewed dozens of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with other pills.

Researchers emphasize that individuals who shed pounds through diet and exercise typically experience a slower weight regain—perhaps 100 grams monthly—post-intervention.

Understanding the Quick Rebound

Doctors propose the mode of action of the drugs explains the heightened rebound.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.

"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the body to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this medication means appetite is no longer kept in check, making overeating much more probable."

A Chronic Disease?

Medical guidelines advise the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

Professionals argue that, due to the likelihood of relapse, the therapy should be considered long-term.

This opinion is echoed by pharmaceutical companies, who note that the results "highlight the chronic nature of obesity," comparing it to managing conditions like diabetes.

User Testimonies

Users who have come off the jabs explain a sudden resurgence of hunger.

"It felt as if a trigger that goes on and you become ravenous," recalled a patient.

This difficulty is compounded if users have not adopted lasting lifestyle or habit modifications during therapy.

Widespread Interest

Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.

  • Use is higher among women compared to males.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion access the medications through private healthcare rather than the NHS.

Ultimately, clinicians emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a permanent cure and maintained weight loss relies on integrated lifestyle changes.

ES
The writer

Emily Sanchez

Alex is a seasoned poker player and writer, sharing insights on UK online poker since 2015.

Brit Poker Online UK

Type to search articles.